These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 1820292
1. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure. Cohn JN. Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292 [Abstract] [Full Text] [Related]
3. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group. Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN. Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244 [Abstract] [Full Text] [Related]
4. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [Abstract] [Full Text] [Related]
7. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Circulation; 1993 Jun; 87(6 Suppl):VI17-23. PubMed ID: 8500235 [Abstract] [Full Text] [Related]
8. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Circulation; 1993 Jun; 87(6 Suppl):VI24-31. PubMed ID: 8500236 [Abstract] [Full Text] [Related]
16. Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. Cohn JN. Drugs; 1994 Jun 12; 47 Suppl 4():47-57; discussion 57-8. PubMed ID: 7523062 [Abstract] [Full Text] [Related]
19. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group. Wong M, Johnson G, Shabetai R, Hughes V, Bhat G, Lopez B, Cohn JN. Circulation; 1993 Jun 12; 87(6 Suppl):VI65-70. PubMed ID: 8500242 [Abstract] [Full Text] [Related]
20. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination. Cheng JW. Clin Ther; 2006 May 12; 28(5):666-78. PubMed ID: 16861089 [Abstract] [Full Text] [Related] Page: [Next] [New Search]